Congratulations! Fifteen Editorial Board Members of RDODJ Named among 2025 World's Top 2% of Scientists!

On September 19, 2025, Stanford University and Elsevier released the 2025 World's Top 2% Scientists list, a prestigious ranking identifying the top 2% of scientists worldwide. The assessment, covering nearly 7 million researchers across 22 fields and 174 sub-disciplines, provides a transparent, objective, and comprehensive evaluation of scientific impact and research accomplishments.

We are delighted to share that 15 Editorial Board members of Rare Disease and Orphan Drugs Journal (RDODJ) have been recognized: 11 on the "Career-long Scientific Impact" list and 13 on the "Annual Scientific Impact" list.

This recognition underscores the valuable contributions of these scholars in advancing rare disease research and translational medicine. Their expertise and dedication support RDODJ's ongoing mission to publish high-quality, impactful research. We sincerely appreciate their commitment and are honored to have such distinguished scholars guiding the journal.

Editor: Monica
Language Editor: Catherine Yang
Production Editor: Ting Xu
Respectfully submitted by the Editorial Office of Rare Disease and Orphan Drugs Journal